The ultimate guide to Medication Safety Week
Julianne Chong
BPharm (Hons), MClinPharm, GCHealthServMgt (Safe&Qual), FANZCAP (Anticoag., Steward) | VTE/Anticoagulation Stewardship and QUM Pharmacist | Concord Repatriation General Hospital | julianne.chong@health.nsw.gov.au
Russell Levy
BPharm, MClinPharm, FSHP, FANZCAP (Lead&Mgmt, Med Safety), FPS | Director of Pharmacy | Royal Prince Alfred Hospital
Garry Soo
BPharm, MClinPharm, FANZCAP (Lead&Mgmt, MedSafety) | Director of Pharmacy | Concord Repatriation General Hospital
Jocelyn Ong
BPharm, MBA | Director of Pharmacy | Canterbury Hospital
Rosemary Burke (PSM)
BPharm, Dip Ed, FSHP, FANZCAP (Lead&Mgmt, MedSafety) | Director of Pharmacy & Chief Pharmacy Information Officer | Sydney Local Health District
[Pharmacy GRIT article no: 20241398]
Medication Safety involves ensuring safe, judicious, and efficacious use of medicines to prevent patient harm.1 Suboptimal use of medicines has been observed across the healthcare continuum from the initial prescribing process, dispensing of medications, and the point of administration.2 Medication errors have led to patient harm such as increases in hospital length of stay, patient morbidity, and death.3 The global financial impact of medication errors has been estimated at $42 billion USD annually.4
The importance of Medication Safety has been promoted in the World Health Organization’s (WHO) Medication without Harm global initiative5 and has been recognised as a Joint Commission National Patient Safety Goal.6 Locally, the National Safety and Quality Health Service (NSQHS), Medication Safety Standard, mandates the need for healthcare organisations to facilitate ongoing efforts to improve Medication Safety for patients under their care.1
To build on these messages and engaging both clinicians and the broader community, we implemented a novel Medication Safety Week (MSW) health promotion across five hospitals within a Sydney metropolitan health district between 12–16 September 2022. This coincided with the WHO’s World Patient Safety Day 2022 theme: ‘Medication without Harm’ which was also celebrated by a special article series authored by the SHPA Specialty Practice Medication Safety Leadership Committee.7 The engaging promotion was also run between 25–29 September 2023 to coincide with World Pharmacist Day.
Planning and core activities
In 2022, we pulled together an enthusiastic district MSW pharmacy team comprised of 13 pharmacists and pharmacy technicians with representation across five hospital sites. An implementation plan was developed and progressed over three months with fortnightly to weekly meetings facilitated virtually via Microsoft (MS) Teams (Microsoft Corporation, Redmond, WA, USA). We also successfully obtained $500 AUD of district funding to support the project.
Figure 1. Medication Safety Week 2022 promotional flyer
A MS Excel spreadsheet was shared electronically on Teams to allow members to collaboratively organise ideas, plan for activities, allocate budget, and to prepare a communication and promotion strategy. There were several core activities undertaken for MSW 2022 (see Figure 1) aimed at increasing engagement with Medication Safety messages and incentivising participation. These included education seminars, promotional stalls, and daily quizzes.
Figure 2. 2022 promotion stall
L to R from Concord Repatriation General Hospital:
Betty Wong (Ph), Trina Ahmad (Ph), Katherine Borg (Ph), Francis Pang (Ph), Julianne Chong (Ph), Chin Yen Yeo (Ph), Nina Phan (Ph), James Pan (Ph), Jessica Iannacito (Ph), Edward Chang (MO).
Ph = pharmacist; MO = medical officer
In addition, we incentivised participation on training modules and held education sessions for consumers. These incentives are described below.
Promotion of the MSW event included advertising on the district intranet bulletin board, an email announcement from the Chief Executive of the Sydney Local Health District, daily emails from the MSW team throughout the week, and the distribution of flyers designed by the district communications team across facilities.
Growing the impact
Engagement with the 2022 MSW event was considerable:
- 262 staff attended our Medication Safety seminars
- 421 staff and consumers completed a Medication Safety quiz
- 240 staff and consumers visited our Medication Safety stalls
- 98 consumers attended our multi-lingual community presentations in Cantonese, Mandarin, and Korean.
- 357 HETI modules were completed by 137 staff.
The successful 2022 framework was then expanded in 2023. A team of 40 pharmacists and technicians commenced preparations in April 2023 and district funding for 2023 MSW was increased to $1000. This facilitated adding additional promotional strategies including the implementation of an electronic banner for MSW on our district intranet page and, to expand promotion to other hospital districts, a post on the SHPA Medication Safety forum and email distribution through pharmacy schools at the University of Sydney, the University of NSW, and University of Technology Sydney.
Figure 3. Medication Safety Week 2023 promotional flyer
Building on the previous years’ campaign, additional enhancements were added in 2023 and outlined here (see Figure 3).
Figure 4. Positivity prescription
In 2023:
- 184 staff attended our Medication Safety seminars
- 472 staff and consumers completed a Medication Safety quiz
- 201 staff and consumers visited our Medication Safety stalls
- 117 consumers attended our community presentations in Cantonese, Mandarin, and Korean
- 86 HETI modules were completed by 56 staff
- 8 consumers attended our workshop.
Despite increases in consumer attendance and Medication Safety quiz completion between 2022 and 2023, there were reductions in staff seminar attendance, stall visits, and HETI module completion. It is possible that with smaller incentives ($10 coffee vouchers instead of $25 gift card for activity attendance and $50 gift cards instead of $100 for module completion) may have affected participation rates. Also, with a larger variety of activities and more opportunities to participate in MSW, such as the ward imprest competition, less staff may have participated in individual activities. Individual MSW activities may have been less prominent in our promotion of MSW due to the greater volume of events.
Feedback from our consumer workshop, which was facilitated by six pharmacists, was overwhelmingly positive:
“All the presenters were very good and gave great presentations that were easy to understand and very interesting. Learnt a few things I was unaware could be harmful if instructions aren’t followed.”
“I would attend any updated presentations as this one was very good.”
Despite the uncertain effectiveness of healthcare provider education on reducing medication error rates in hospital,8 promotion of Medication Safety, particularly for high-risk medicines, remains a strategy healthcare facilities should implement as an adjunct to other initiatives to meet NSQHS Standards.1 Our successful implementation of a district wide MSW promotion with high impact was one step towards minimising avoidable patient harm from medication. Incentivising staff to dedicate time to complete Medication Safety modules and to attend education sessions was particularly effective. We believe our framework for MSW could be used at other healthcare facilities as an ongoing annual initiative to educate key audiences on Medication Safety with the flexibility to focus on different areas of need annually.
Acknowledgements
The authors would like to acknowledge the contributions of Alexander McNamara, Carolyn Woods, Sabrina Wu, Seniha Kasif, Sohileh Aran, Omar Mubaslat, Hannah Turton, Rebekah Lee, Hari Kim, Vicki Zhang, Susanna Yang, Seung (Sarah) An, Linda Do, Trina Ahmad, Katherine Borg, Bruce Wu, and Grace Moujalli, as well as the pharmacy departments of Concord Repatriation General Hospital, Royal Prince Alfred Hospital, Canterbury Hospital, Balmain Hospital, and the Concord Centre for Mental Health.
References
- Australian Commission on Safety and Quality in Health Care (ACSQHC). Medication Safety Standard. Sydney: ACSQHC; 2023. Available from: https://www.safetyandquality.gov.au/standards/nsqhs-standards/medication-safety-standard. Accessed 22 December 2023.
- Manias E, Kusljic S, Wu A. Interventions to reduce medication errors in adult medical and surgical settings: a systematic review. Ther Adv Drug Saf 2020; 11: 2042098620968309.
- Sodré Alves BMC, de Andrade TNG, Cerqueira Santos S, Goes AS, Santos ADS, Lyra Júnior DP, et al. Harm prevalence due to medication errors involving high-alert medications: a systematic review. J Patient Saf 2021; 17: e1–e9.
- World Health Organization (WHO). WHO global patient safety challenge. Geneva: WHO; 2017. Available from https://iris.who.int/bitstream/handle/10665/255263/WHO-HIS-SDS-2017.6-eng.id=23E3E58293025B546A38236B7882AFC7?sequence=1. Accessed 22 December 2023.
- WHO. Medication without harm. Geneva: WHO; 2023. Available from https://www.who.int/initiatives/medication-without-harm. Accessed 22 December 2023.
- The Joint Commission. National patient safety goals®: effective July 2023 for the hospital program. Oakbrook Terrace, IL: The Joint Commission; 2023. Available from: https://www.jointcommission.org/-/media/tjc/documents/standards/national-patient-safety-goals/2023/npsg_chapter_hap_jul2023.pdf. Accessed 22 December 2023.
- Medication Safety Leadership Committee. World Patient Safety Day series 2022. Collingwood, VIC: Society of Hospital Pharmacists of Australia; 2022. Available from https://www.adpha.au/publications-resources/medication-safety/world-patient-safety-day-series. Accessed 29 February 2024.
- Ciapponi A, Fernandez Nievas SE, Seijo M, Rodríguez MB, Vietto V, García-Perdomo HA, et al. Reducing medication errors for adults in hospital settings. Cochrane Database Syst Rev 2021; 2021(11): CD009985.